Good morning, and welcome to the first SCVR of 2015. I hope you are suitably refreshed from the festive break, and raring to go!

Unfortunately it doesn't look like many companies are raring to go today, with only one set of results, and no trading statements coming up on the RNS. So whilst everyone else was singing Auld Lang Syne, only the Directors of ISDX-listed Hot Rocks Investments (OFEX:HRIP) were signing off their accounts, although the figures look poor.

It's a tiny investment company, in junior resource stocks. Net assets were only £1.06m at 30 Sep 2014, so presumably the value of their investments is likely to have fallen considerably since then, given the carnage in the sector.

With £49k operating expenses in six months, that means that administration costs in a full year would be just under 10% of funds under management. How can that possibly make sense? The market cap of £1.7m looks too high in comparison with net assets, unless the company has some hidden assets that are under-stated on the Balance Sheet?

I'm only really mentioning it because there's nothing else to write about today. Although talking about the ISDX market, I have been meaning for some time to review every stock on this market. The reason being that in the past I've spotted one or two interesting companies on ISDX (it's a very small market, formerly called Plus Markets, and OFEX). As very few investors look at ISDX stocks, you are more likely to find pricing anomalies - i.e. usually stocks which are completely overlooked. A good example some time ago was Sprue Aegis (LON:SPRP) - a friend flagged up that company to me when it was listed on ISDX and was about 92p. It was a stonking buy at that price, and the value was obvious, but hardly anyone knew it even existed. Those shares have since more than tripled, and the company has moved up to AIM.

As someone wisely mentioned on Twitter the other day, a good way to make money is to find an illiquid market, and then become an expert in it. To a large extent that sums up my approach, although you can still find plenty of pricing anomalies in fairly liquid small to mid caps too.


Afren (LON:AFR)

It's not…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here